| DOC |
Report |
Adjusted FFO/share |
BEAT |
pred ~$0.400 vs. cons $0.395 (VA, Aug. 4; definition UNVERIFIED) |
LOW |
| DOC |
Report |
Life-science same-store NOI growth |
MISS |
pred ~-6.5% vs. cons -5.72% (VA, Aug. 4) |
LOW |
| DOC |
Report |
Senior-living same-store NOI growth |
MISS |
pred ~+16.0% vs. cons +16.97% (VA, Aug. 4) |
LOW |
| DOC |
Guide |
FY2026 FFO as Adjusted ($/share) |
BETTER |
guide ~$1.71-$1.75 vs. cons $1.570 (VA, Aug. 4; guide from May 5 release) |
LOW |
| DOC |
Guide |
Life-science occupancy commentary (FY2026) |
UNCHANGED |
reiterate improving through year-end vs. no reliable numeric consensus |
LOW |
| DOC |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.5% |
— |
LOW |
| DOC |
Return |
5-day cumulative residual |
-5.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — maintained guide plus lab miss pressures forward estimates |
LOW |